JINGSAI
871981
HENGHE CO.,LTD.
832145
EC PERCISION
836221
CG MED EQUIP.
838810
MEIBANG TECHNOLOGY
832471
CN Stock MarketDetailed Quotes
603127 Joinn Laboratories
- 21.62
- -0.25-1.14%
Not Open Mar 17 15:00 CST
16.20BMarket Cap-21620.00P/E (TTM)
21.85High21.36Low76.21KlotVolume21.84Open21.87Pre Close164.11MTurnover1.21%Turnover Ratio40.79P/E (Static)749.48MShares23.2052wk High2.02P/B13.63BFloat Cap12.1652wk Low24.06Limit Up630.48MShs Float92.24Historical High19.68Limit Down2.24%Amplitude1.45Historical Low0.16Dividend TTM21.53Avg Price35.32KlotAsk0.74%Div YieldTTM100Lot Size36.51KlotBid
Joinn Laboratories News
Zhaoyan Pharmaceutical: Zhaoyan Pharmaceutical\'s progress announcement on the repurchase of the company\'s A-share shares through centralized bidding transactions
Zhaoyan Pharmaceutical: Zhaoyan Pharmaceutical\'s progress announcement on the repurchase of the company\'s A-share shares through centralized bidding transactions
Zhaoyan Pharmaceutical: Announcement of Resolutions of Zhaoyan Pharmaceutical\'s 2025 First Extraordinary General Meeting of Shareholders, 2025 First Class A Shareholders\' Meeting, and 2025 First H Share Class Shareholders\' Meeting
Zhaoyan New Pharmaceutical: Legal Opinions of Beijing Tianyuan Law Firm on the 2025 First Extraordinary General Meeting of Shareholders of Zhaoyan New Pharmaceutical, the First Class A Shareholders\' Meeting in 2025, and the First Class H Shareholders\' Meeting in 2025
Legal Opinions of Beijing Tianyuan Law Firm on the 2025 First Extraordinary General Meeting of Shareholders of Zhaoyan New Pharmaceutical, the First Class A Shareholders\' Meeting in 2025, and the First Class H Shareholders\' Meeting in 2025
Announcement of Resolutions of Zhaoyan Pharmaceutical\'s 2025 First Extraordinary General Meeting of Shareholders, 2025 First Class A Shareholders\' Meeting, and 2025 First Class H Shareholders\' Meeting
Notice of Zhaoyan Pharmaceutical on holding the first extraordinary general meeting of shareholders in 2025, the first A-share shareholders\' meeting in 2025, and the first H-share shareholders\' meeting in 2025
Information on the 2025 First Extraordinary General Meeting of Shareholders of Zhaoyan Pharmaceutical, the first Class A Shareholders\' Meeting in 2025, and the First Class H Shareholders\' Meeting in 2025
Announcement of Beijing Zhaoyan Pharmaceutical Research Center Co., Ltd. on the resignation of directors and by-election of directors
Announcement of Zhaoyan New Pharmaceutical on cooperating with professional investment institutions to participate in the establishment of a fund
Announcement of Zhaoyan New Pharmaceutical on cooperating with professional investment institutions to participate in investment funds
Zhaoyan Pharmaceutical: Zhaoyan Pharmaceutical\'s progress announcement on the repurchase of the company\'s A-share shares through centralized bidding transactions
Zhaoyan Pharmaceutical: Announcement of Zhaoyan New Pharmaceutical on cooperating with professional investment institutions to participate in the establishment of an industrial fund
Zhaoyan Pharmaceutical: Announcement of Beijing Zhaoyan New Drug Research Center Co., Ltd. on changing the company\'s registered capital and amending the company\'s articles of association
Zhaoyan New Pharmaceutical: Announcement of Zhaoyan New Pharmaceutical on the Resignation of Directors and the By-election of Non-Independent Directors
Announcement of Beijing Zhaoyan Pharmaceutical Research Center Co., Ltd. on changing the registered capital of the company and amending the company\'s articles of association
Announcement of Zhaoyan New Pharmaceutical on cooperating with professional investment institutions to participate in the establishment of industrial funds
Announcement of Zhaoyan Pharmaceutical regarding the resignation of directors and by-election of non-independent directors
Zhaoyan Pharmaceutical: Zhaoyan Pharmaceutical\'s progress announcement on the repurchase of the company\'s A-share shares through centralized bidding transactions
Resolutions of the 2nd Special Meeting of Independent Directors of Zhaoyan Pharmaceutical in 2024
